+Search query
-Structure paper
Title | Selective and Bioavailable HDAC6 2-(Difluoromethyl)-1,3,4-oxadiazole Substrate Inhibitors and Modeling of Their Bioactivation Mechanism. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 66, Page 14188-14207, Year 2023 |
Publish date | Feb 12, 2023 (structure data deposition date) |
Authors | Ripa, L. / Sandmark, J. / Hughes, G. / Shamovsky, I. / Gunnarsson, A. / Johansson, J. / Llinas, A. / Collins, M. / Jung, B. / Noven, A. ...Ripa, L. / Sandmark, J. / Hughes, G. / Shamovsky, I. / Gunnarsson, A. / Johansson, J. / Llinas, A. / Collins, M. / Jung, B. / Noven, A. / Pemberton, N. / Mogemark, M. / Xiong, Y. / Li, Q. / Tangefjord, S. / Ek, M. / Astrand, A. |
External links | J. Med. Chem. / PubMed:37797307 |
Methods | X-ray diffraction |
Resolution | 1.51 Å |
Structure data | PDB-8cj7: |
Chemicals | ChemComp-K: ChemComp-ZN: ChemComp-UTO: ChemComp-IOD: ChemComp-HOH: |
Source |
|
Keywords | HYDROLASE / inhibitor / small molecule hydrazide / HDAC6 / oxadiazole / histone |